Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials.
Susanne Ostrowitzki,Tobias Bittner,Kaycee M Sink,Howard Mackey,Christina Rabe,Lawrence S Honig,Emanuele Cassetta,Michael Woodward,Mercè Boada,Christopher H van Dyck,Timo Grimmer,Dennis J Selkoe,Andres Schneider,Kathleen Blondeau,Nan Hu,Angelica Quartino,David Clayton,Michael Dolton,Yifan Dang,Beth Ostaszewski,Sandra M Sanabria-Bohórquez,Michael Rabbia,Balazs Toth,Udo Eichenlaub,Jillian Smith,Lee A Honigberg,Rachelle S Doody JAMA neurology（2022）
摘要
ClinicalTrials.gov Identifiers: CREAD, NCT02670083; CREAD2, NCT03114657.
更多查看译文
AI 理解论文
溯源树
样例
